Your browser doesn't support javascript.
loading
"Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic.
Parisot, John P; Thorne, Heather; Fellowes, Andrew; Doig, Ken; Lucas, Mark; McNeil, John J; Doble, Brett; Dobrovic, Alexander; John, Thomas; James, Paul A; Lipton, Lara; Ashley, David; Hayes, Theresa; McMurrick, Paul; Richardson, Gary; Lorgelly, Paula; Fox, Stephen B; Thomas, David M.
Afiliación
  • Parisot JP; Division of Cancer Research, Peter MacCallum Cancer Centre, 7 St Andrews Place, East Melbourne VIC 3002, Australia. john.parisot@petermac.org.
  • Thorne H; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville VIC 3010, Australia. john.parisot@petermac.org.
  • Fellowes A; Division of Cancer Research, Peter MacCallum Cancer Centre, 7 St Andrews Place, East Melbourne VIC 3002, Australia. heather.thorne@petermac.org.
  • Doig K; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville VIC 3010, Australia. heather.thorne@petermac.org.
  • Lucas M; Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne VIC 3002, Australia. andrew.fellowes@petermac.org.
  • McNeil JJ; Division of Cancer Research, Peter MacCallum Cancer Centre, 7 St Andrews Place, East Melbourne VIC 3002, Australia. ken.doig@petermac.org.
  • Doble B; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville VIC 3010, Australia. ken.doig@petermac.org.
  • Dobrovic A; Department of Epidemiology and Preventative Medicine, Alfred Centre, Monash University, Prahran VIC 3181, Australia. mark.lucas@monash.edu.
  • John T; Department of Epidemiology and Preventative Medicine, Alfred Centre, Monash University, Prahran VIC 3181, Australia. john.mcneil@monash.edu.
  • James PA; Centre for Health Economics, Monash University, Clayton VIC 3800, Australia. brett.doble@monash.edu.
  • Lipton L; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville VIC 3010, Australia. alex.dobrovic@onjcri.org.au.
  • Ashley D; Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne VIC 3002, Australia. alex.dobrovic@onjcri.org.au.
  • Hayes T; Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg VIC 3084, Australia. alex.dobrovic@onjcri.org.au.
  • McMurrick P; Department of Pathology, The University of Melbourne, Parkville VIC 3010, Australia. alex.dobrovic@onjcri.org.au.
  • Richardson G; School of Cancer Medicine, La Trobe University, Bundoora VIC 3084, Australia. alex.dobrovic@onjcri.org.au.
  • Lorgelly P; School of Cancer Medicine, La Trobe University, Bundoora VIC 3084, Australia. Tom.John@onjcri.org.au.
  • Fox SB; Medical Oncology, Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg VIC 3084, Australia. Tom.John@onjcri.org.au.
  • Thomas DM; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne VIC 3002, Australia. paul.james@petermac.org.
J Pers Med ; 5(4): 354-69, 2015 Oct 29.
Article en En | MEDLINE | ID: mdl-26529019
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Pers Med Año: 2015 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Pers Med Año: 2015 Tipo del documento: Article País de afiliación: Australia